Envision Report

Published January 8, 2018

Antiviral Drug Market – Share, Outlook, Trends, Size and Forecasts (2018 – 2024)

Request Free Sample Report!

Antiviral drugs are the ones used for treating viral infections rather than bacterial ones. Antiviral drugs are of antimicrobials which include antibiotic or antiviral drugs based on monoclonal antibodies. The market is estimated to be USD 45.64 Billion by 2024 from USD 32.48 Billion in 2017 at a CAGR of 5.78%.

Global antiviral drug market share:

North America is expected to have the most significant percentage and that is due to the presence of ample opportunities for pharmaceutical companies to market the product and rise in viral infection incidences and increase in public awareness.

Global antiviral drug market size:

Technology, end user and type segment the antiviral drug market. The technology is having the most significant demand as these drugs are used for viral infections such as HIV, herpes, hepatitis and influenza while most of these are used for specific viral infections and few for broad-range of areas.

Global antiviral drug market growth:

The growth of antiviral drug market is majorly driven by an increase in public awareness, rise in healthcare expenditure, R & D development incidence of virus life-threatening diseases and rate of growth of viral infections like HIV herpes and hepatitis.

Global antiviral drug market industry analysis:

The market is classified as technology, end user and type. The technology is segmented into HIV, Hepatitis, herpes and influenza. Type is classified into branded and genetics. Here the primary market is based on the viral infections that are HIV and others.

Global antiviral drug market outlook:

Global antiviral drug market majorly deals with the medication for viral infections. Most antivirals are used for specific viral infections while a broad spectrum antiviral is effective against wide range of viruses. Most of the firms and industries are trying to develop the technologies and monitor the viral infections. The growth is predominant in North America.

Global antiviral drug market Trends:

Johnson & Johnson was offering the world’s most extensive range of consumer healthcare products.Cipla is the world’s largest manufacturer of antiviral drugs and has the products pharmaceutical ingredients to other manufacturers as well as pharmaceuticals and personal care products.

Global antiviral drug market Research reports:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis through industry value chain analysisPorter’s fivePESTLESWOT analysis, and Y-o-Y analysis.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on YearOnYear
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
  • Identify the latest developments, market shares and strategies that are employed by the major market players, such as
  • Massachusetts Institute
  • Abbott Healthcare
  • Johnson and Johnson
  • Roche Holding Ag
  • Cipla
  • Merck & Co

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 Pestle Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5 Market Segmentation Analysis

Chapter 6 Market Segmentation by Technology

6.1 Introduction

6.2 HIV/AIDS therapeutics market

6.3 Hepatitis therapeutics

6.3.1 Hepatitis B

6.3.2 Hepatitis C

6.4 Herpes therapeutics

6.5 Influenza antivirals

6.6 Others

Chapter 7 Market Segmentation by the end user

7.1 Introduction

7.2 Hospitals

7.3 Clinics

7.4 Ambulatory surgical centres

7.5 Others

Chapter 8 Market Segmentation by Type

8.1 Introduction

8.2 Branded

8.3 Genetics

8.4 Others

Chapter 9 Market Segmentation by Geography

9.1 North America

9.1.1 Introduction

9.1.1 USA

9.1.2 Canada

9.1.3 Mexico

9.1.4 Others

9.2 Europe

9.2.1 Introduction

9.2.2 UK

9.2.3 France

9.2.4 Germany

9.2.5 Italy

9.2.6 Spain

9.2.7 Others

9.3 Asia-Pacific

9.3.1 Introduction

9.3.2 Japan

9.3.3 China

9.3.4 India

9.3.5 Australia

9.3.6 South Korea

9.3.7 Others

9.4 South America

9.4.1 Introduction

9.4.2 Brazil

9.4.3 Argentina

9.4.4 Others

9.5 The Middle-East and Africa

9.5.1 Introduction

9.5.2 South Africa

9.5.3 Others

Chapter 10 Competitive Landscape

10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

10.2 Market Share Analysis

10.3 Strategies Adopted By Top Companies

Chapter 11 Company Profiles

11.1 Abbott Healthcare

   11.1.1. Company Overview

11.1.2. Financial Performance

11.1.3. Product Benchmarking

11.1.4. Strategic Initiative

11.2 Johnson and Johnson

11.3 Roche Holding Ag

11.4 Cipla

11.5 Merck & Co

11.6 Gilead

11.7 Schering-Plough

11.8 GlaxoSmithKline

11.9 AstraZeneca

11.10 Bristol-Myers-Squibb

11.11 Schering-Plough

11.12 ImmuneMed

11.13 DR Reddy

Chapter 12 Market Estimates and Forecast

13.1 Market Estimates and Forecast 2018-2024(USD Million)

13.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)

13.1.2 Market Estimates and Forecast by Type 2018-2024 (USD Million)

13.1.3 Market Estimates and Forecast by end user 2018-2024 (USD Million)

13.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)

13.1.5 Market Estimates and forecast by company Profiles 2018-2024(USD million)

Chapter 14 Market Insights

14.1 Insights of Industry Experts

14.2 Analyst Opinion (Market Understanding)

14.3 Investment Opportunities

Chapter 15 Appendix

15.1 List of Tables

15.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

 

©2018 - Envision Inteligence | All Rights Reserved.